Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

236
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
236
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

202
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
202
Introduction to Epidemiology01:26

Introduction to Epidemiology

1.1K
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
1.1K
Causality in Epidemiology01:21

Causality in Epidemiology

987
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
987
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

461
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
461
Clinical Trials01:16

Clinical Trials

9.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mortality As a Measure of Treatment Effect in Clinical Trials Recruiting Critically Ill Patients.

Critical care medicine·2023
Same author

Impact of adherence to procalcitonin antibiotic prescribing guideline recommendations for low procalcitonin levels on antibiotic use.

BMC infectious diseases·2023
Same author

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

JAMA·2022
Same author

Invited commentary on Sepsis.

Surgery·2022
Same author

Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era.

Open forum infectious diseases·2022
Same author

Proteomic changes associated with racial background and sepsis survival outcomes.

Molecular omics·2022

Related Experiment Video

Updated: Sep 29, 2025

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.2K

Clinical Evidence Generation During a Pandemic: Lessons Learned for Sustaining Progress.

Donna R Rivera1, Paul G Kluetz1, Kald Abdallah2

  • 1From the Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD.

Cancer Journal (Sudbury, Mass.)
|March 25, 2022
PubMed
Summary

The COVID-19 pandemic spurred innovations in oncology care and research, leading to improved clinical trial designs and evidence generation. Lessons learned can accelerate cancer drug development and enhance health equity post-pandemic.

More Related Videos

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.0K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.4K

Related Experiment Videos

Last Updated: Sep 29, 2025

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.2K
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.0K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.4K

Area of Science:

  • Oncology
  • Health Services Research
  • Clinical Trials

Background:

  • The COVID-19 pandemic necessitated significant adaptations in healthcare delivery and clinical research.
  • These changes created opportunities to evaluate new approaches for generating evidence in oncology.
  • A workshop convened by the National Academies of Sciences, Engineering, and Medicine focused on lessons learned from the pandemic's impact on cancer care and research.

Purpose of the Study:

  • To examine pandemic-driven changes in cancer care and research.
  • To identify lessons learned that can improve future cancer care delivery and clinical trial conduct.
  • To emphasize the role of health equity in advancing cancer research and treatment.

Main Methods:

  • Virtual workshop hosted by the National Cancer Policy Forum on July 26-27, 2021.
  • Discussion and examination of adaptations in cancer care and clinical research during the COVID-19 pandemic.
  • Analysis of potential strategies to sustain positive changes and accelerate progress.

Main Results:

  • The pandemic experience catalyzed research efficiencies and fostered diverse trial designs.
  • New research methods emerged that can facilitate improved cancer drug development.
  • The focus on adapting care delivery highlighted opportunities for enhancing health equity.

Conclusions:

  • Valuable lessons from the pandemic can accelerate progress in oncology.
  • Sustaining innovations can improve clinical evidence generation for patients and clinicians.
  • The pandemic's impact offers a unique opportunity to reshape cancer research for a more equitable future.